Blog

Computacenter (LSE:CCC) posted strong revenue gains in the first half of 2025, driven mainly by its Technology Sourcing division, with particularly solid results in North America and the UK markets. However, the business encountered difficulties in Germany and France, where political shifts have disrupted public sector projects.

Although net interest income declined following a share buyback, the company’s balance sheet remains healthy. With a substantial product order backlog, Computacenter is well-positioned to navigate the remainder of the year. While geopolitical tensions and macroeconomic challenges persist, there is optimism for a partial rebound in Germany’s public sector activity, though conditions in France continue to pose challenges.

Computacenter’s financial strength and recent corporate developments contribute positively to its stock rating, reflecting strong revenue momentum and a favorable outlook. Nonetheless, bearish technical signals weigh on the overall assessment. The company’s valuation is reasonable, offering moderate income potential.

About Computacenter

Computacenter is a leading independent provider of technology and IT services, supporting major corporate and public sector clients. The company specializes in sourcing, transforming, and managing technology infrastructure to enable digital transformation. Listed on the London FTSE 250, Computacenter employs over 20,000 people globally.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Ceres Power Holdings (LSE:CWR) and Doosan Fuel Cell (USOTC:DOOSF) have officially started mass production of fuel cell power systems featuring Ceres’ solid oxide technology at Doosan’s manufacturing site in South Korea. This launch marks a key milestone, as Doosan becomes the first strategic partner to scale production, focusing on markets such as AI/data centers and commercial power applications.

The partnership aims to address the growing energy demands driven by AI advancements while supporting the global shift toward a low-carbon future. Initial sales will concentrate on South Korea, targeting use cases including stationary distributed power, data centers, renewable energy grids, and maritime shipping.

Ceres Power’s robust revenue growth and strong strategic alliances are promising, though ongoing profitability challenges and valuation concerns temper the outlook. Technical indicators are showing bullish momentum, complemented by positive corporate developments and encouraging earnings call feedback, resulting in a moderately optimistic forecast.

About Ceres Power Holdings

Ceres Power Holdings plc is a frontrunner in clean energy innovation, specializing in fuel cells for power generation and electrolysers for green hydrogen production. Operating with an asset-light licensing model, the company collaborates with major global partners. Ceres’ solid oxide technology plays a crucial role in advancing energy electrification and enabling efficient green hydrogen production, aiding decarbonization efforts in industries like steelmaking and ammonia manufacturing. Listed on the London Stock Exchange, Ceres is recognized as a significant contributor to the transition toward a sustainable green economy.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Kooth plc (LSE:KOO) has released its half-year trading update, highlighting operational progress and key leadership changes aimed at supporting its growth ambitions. Now in the third year of its major contract with the State of California, the company’s Soluna platform has experienced significant expansion, attracting over 128,000 young users.

Despite uncertainties around potential federal healthcare funding cuts, Kooth’s focus on youth mental health remains well-aligned with California’s priorities, helping to sustain demand. In the UK, the company maintains a stable position amid fiscal challenges and is preparing to roll out Soluna to broaden its service offerings.

To support its strategic goals and international expansion, Kooth has bolstered its leadership team, positioning the business for sustainable long-term growth.

About Kooth plc

Kooth plc is a leading digital mental health service provider, delivering accessible and secure platforms for mental wellbeing. The company focuses on early intervention and prevention through a range of therapeutic supports and interventions. Accredited by the British Association of Counselling and Psychotherapy, Kooth is the UK’s largest provider of mental health support for under-18s. The company is actively expanding internationally, with a strong focus on the growing youth mental health market in the US.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cranswick plc (LSE:CWK) reported a strong start to its financial year, with first-quarter revenue rising 9.7% year-on-year. This growth was fueled by new business wins and robust demand for the company’s premium product range. The recent acquisition of Blakemans also added to the positive momentum, while export revenues received a boost following the reinstatement of the China export license for its Norfolk pork facility.

The company is stepping up capital expenditure to improve capacity and operational efficiency, with significant investments planned for its Lincoln Pet Products site. Additionally, Cranswick has refinanced its banking arrangements, securing a £360 million revolving credit facility designed to support its ongoing growth ambitions.

Cranswick’s strong financial results, underpinned by healthy revenue and profitability gains, contribute to a favorable stock outlook. Recent corporate developments, including insider buying and strategic initiatives, further bolster confidence in the company’s future trajectory. However, technical analysis suggests a neutral outlook in the near term, and valuation metrics remain fair, reflecting the company’s growth prospects.

About Cranswick

Cranswick is a leading UK food manufacturer known for its premium fresh and added-value products. Operating 23 sites across the country, the company produces a diverse portfolio including fresh pork, poultry, gourmet foods, and pet products. Cranswick supplies major supermarket chains and holds a strong position in both the food-to-go sector and export markets.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Science Group plc (LSE:SAG) reported strong interim financial results for the first half of 2025, with profit before tax rising significantly to £32.2 million. This increase was largely driven by a successful investment in Ricardo plc, which contributed a pre-tax return of £24.0 million.

Despite facing headwinds in its Professional Services Division, the Group’s adjusted operating profit improved, buoyed by solid performances within its Systems businesses. Additionally, Science Group strengthened its liquidity position, ending June 2025 with a robust cash balance of £82.0 million, providing a strong foundation for future growth initiatives.

Looking ahead, the company’s outlook is supported by solid financials and positive corporate developments. However, technical indicators such as an overbought Relative Strength Index (RSI) highlight some short-term risks. Valuation appears fair, though investors should keep a close watch on the performance of Ricardo, given its material impact on the Group’s results.

About Science Group plc

Science Group plc is a global Professional Services and Systems provider focused on driving innovation through science, technology, and engineering. The company reinvests capital generated from operations into strategic corporate opportunities, aiming to create attractive shareholder value through disciplined capital deployment and leveraging its specialized expertise.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Alien Metals Ltd (LSE:UFO), in partnership with West Coast Silver Limited, has announced noteworthy assay outcomes from the Elizabeth Hill Silver Project located in Western Australia. The findings reveal elevated concentrations of silver, copper, and gold, pointing to the discovery of multiple new mineralized zones.

These promising results significantly enhance the exploration potential of the Elizabeth Hill site, strengthening Alien Metals’ position within the mining sector and supporting the company’s ongoing efforts to expand its resource base.

About Alien Metals Ltd

Alien Metals Ltd is a London AIM-listed mining exploration and development company. Its primary focus is the profitable development of the Hancock iron ore project in Western Australia through direct shipping operations. Additionally, the company holds interests in several other iron ore exploration projects and maintains a joint venture stake in the Elizabeth Hill Silver Project.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

GlaxoSmithKline plc (LSE:GSK) has formed a strategic collaboration with Hengrui Pharma (USOTC:JHPCY) to jointly develop up to twelve innovative therapies across Respiratory, Immunology & Inflammation, and Oncology. Central to the partnership is the development of a potentially best-in-class PDE3/4 inhibitor aimed at treating COPD.

The agreement features a $500 million upfront payment from GSK, alongside potential milestone payments that could total as much as $12 billion. By combining GSK’s extensive global reach with Hengrui’s early-stage discovery expertise, the partnership seeks to accelerate the advancement and commercialization of promising new medicines, enhancing GSK’s competitive positioning and expanding treatment options for patients worldwide.

GSK continues to demonstrate steady financial results, supported by strategic initiatives that drive growth. Recent corporate developments and earnings communications underscore the company’s proactive approach, while technical indicators suggest a neutral market stance. The stock’s valuation remains reasonable, offering potential income through dividends.

About GlaxoSmithKline

GSK is a leading global biopharmaceutical company dedicated to improving health through innovative science, advanced technology, and a skilled workforce. Hengrui Pharma is an international pharmaceutical firm focused on developing high-quality treatments for unmet medical needs, with core expertise in oncology, metabolic and cardiovascular diseases, immune and respiratory disorders, and neuroscience.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

SolGold plc (LSE:SOLG) has announced promising progress at its Tandayama-América deposit, a key component of the Cascabel Project in Ecuador. Initial drilling results from the first three holes have confirmed multiple high-grade copper and gold intersections, prompting the company to accelerate exploration efforts by deploying a fourth drill rig.

The ramped-up drilling campaign is aimed at evaluating the potential for integrating open-pit production from Tandayama with the planned underground operations at Alpala. This dual approach is central to SolGold’s strategy of developing a phased open-pit and underground mining complex, which could enhance project flexibility and shorten production timelines.

While SolGold continues to face financial headwinds—characterized by ongoing losses and negative cash flow—its operational progress and recent strategic initiatives offer reasons for cautious optimism. Improvements in governance and continued investment activity may support the company’s efforts to strengthen its market position, although current valuation metrics remain weak.

About SolGold plc

SolGold is a mineral exploration and development company focused on discovering and advancing world-class copper and gold assets. The company’s flagship project, Cascabel in northern Ecuador, is among the most significant undeveloped copper-gold resources globally. SolGold is committed to responsible exploration and value creation for its shareholders through strategic development and disciplined execution.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Dotdigital Group plc (LSE:DOTD) has issued a positive trading update for the fiscal year 2025, reporting a 6% year-on-year increase in group revenue to £83.9 million. Notably, 94% of this income came from recurring sources, underscoring the company’s focus on predictable, high-margin SaaS revenue.

Profitability also saw strong double-digit growth, supported by rising demand for Dotdigital’s data-driven personalization tools, AI capabilities, and scalable marketing automation solutions. The company further strengthened its international presence with the acquisition of US-based Social Snowball, expanding its offering into influencer marketing and enriching its cross-channel engagement platform.

The integration of Social Snowball marks a strategic step forward, aligning with Dotdigital’s long-term vision of driving recurring revenue through innovation and selective M&A activity. Larger client wins and international revenue growth suggest continued momentum, even amid challenging macroeconomic conditions.

Despite some technical and valuation concerns, the company’s strong financials and strategic execution are fueling optimism about its growth prospects.

About Dotdigital Group plc

Dotdigital Group plc is a UK-based provider of advanced marketing automation solutions, designed to help brands deliver personalized, data-driven customer experiences at scale. Its Customer Experience and Data Platform (CXDP) integrates AI, analytics, and automation to support marketers in building unified customer journeys across multiple channels. Founded in 1999 and headquartered in London, Dotdigital now serves over 4,000 brands in more than 150 countries, helping businesses drive engagement, conversion, and customer loyalty worldwide.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Aferian plc (LSE:AFRN) has reported a solid financial rebound in the first half of 2025, with revenues rising 36% year-on-year to $16.6 million. The company also posted a return to profitability, achieving an adjusted EBITDA of $1.7 million. This performance was largely fueled by a 94% increase in revenue from its Amino segment, while the 24i division delivered stable results despite some customer attrition.

Although Aferian is currently renegotiating its banking arrangements—introducing a degree of financial uncertainty—it remains optimistic about its strategic direction. Management expects full-year revenue to exceed the previous year’s total by approximately 20%, reinforcing confidence in the company’s growth trajectory.

About Aferian plc

Aferian plc is a business-to-business provider of video streaming technology, offering end-to-end solutions for video content delivery. Operating under its Amino and 24i brands, the company serves clients across the Pay TV, enterprise video, and digital signage sectors. Aferian focuses on software and services that enable seamless, flexible video experiences across devices and platforms, catering to a global customer base.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.